Long-term follow-up of 12 patients with the late-onset variant of argininosuccinic acid lyase deficiency: no impairment of intellectual and psychomotor development during therapy
- PMID: 1594374
Long-term follow-up of 12 patients with the late-onset variant of argininosuccinic acid lyase deficiency: no impairment of intellectual and psychomotor development during therapy
Abstract
To date, two variants of argininosuccinic acid lyase deficiency, the second most common enzymatic defect of the urea cycle, have been described. Most of the previous studies reported on outcomes involving neurological and intellectual impairment in affected children. This study is the first to demonstrate that the physical and mental development of such children can be normal and adequate for their age if they are treated with a low-protein diet and/or arginine supplements. Since 1973, 12 Austrian children suffering from argininosuccinic acid lyase deficiency have been detected in the Austrian Neonates Screening Program and could have been followed up. After confirmation of diagnosis, all the children were administered a daily arginine supplement (3 to 4 mmol/kg per day) in conjunction with either a normal diet or a special diet in which protein intake was restricted to 1.2 to 1.5 g/kg per day. Routine checks, including physical examination, determination of biochemical parameters, and IQ tests, were performed so the further development of these 12 patients with respect to treatment could be observed. It can be concluded that early treatment of partial argininosuccinic acid lyase deficiency results in normal intellectual and psychomotor development.
Similar articles
-
Long-term follow-up of 58 patients with histidinemia treated with a histidine-restricted diet: no effect of therapy.Pediatrics. 1994 Dec;94(6 Pt 1):861-6. Pediatrics. 1994. PMID: 7971002
-
[Argininosuccinic aciduria. A new case revealed by psychiatric disorders].J Genet Hum. 1989 Jan;37(1):39-42. J Genet Hum. 1989. PMID: 2715782 French.
-
A neonatal screening test for argininosuccinic acid lyase deficiency and other urea cycle disorders.Pediatrics. 1982 Oct;70(4):526-31. Pediatrics. 1982. PMID: 7122151
-
Urea cycle disorders: clinical presentation outside the newborn period.Crit Care Clin. 2005 Oct;21(4 Suppl):S9-17. doi: 10.1016/j.ccc.2005.05.007. Crit Care Clin. 2005. PMID: 16227115 Review.
-
[Argininosuccinate lyase deficiency].Ryoikibetsu Shokogun Shirizu. 1998;(18 Pt 1):179-81. Ryoikibetsu Shokogun Shirizu. 1998. PMID: 9590021 Review. Japanese. No abstract available.
Cited by
-
Optimizing therapy for argininosuccinic aciduria.Mol Genet Metab. 2012 Sep;107(1-2):10-4. doi: 10.1016/j.ymgme.2012.07.009. Epub 2012 Jul 20. Mol Genet Metab. 2012. PMID: 22841516 Free PMC article. Review.
-
A randomized controlled trial to evaluate the effects of high-dose versus low-dose of arginine therapy on hepatic function tests in argininosuccinic aciduria.Mol Genet Metab. 2012 Nov;107(3):315-21. doi: 10.1016/j.ymgme.2012.09.016. Epub 2012 Sep 17. Mol Genet Metab. 2012. PMID: 23040521 Free PMC article. Clinical Trial.
-
Alternative pathway therapy for urea cycle disorders.J Inherit Metab Dis. 1998;21 Suppl 1:101-11. doi: 10.1023/a:1005365825875. J Inherit Metab Dis. 1998. PMID: 9686348 Review.
-
Incidence, disease onset and short-term outcome in urea cycle disorders -cross-border surveillance in Germany, Austria and Switzerland.Orphanet J Rare Dis. 2017 Jun 15;12(1):111. doi: 10.1186/s13023-017-0661-x. Orphanet J Rare Dis. 2017. PMID: 28619060 Free PMC article.
-
Bacterial expression of mutant argininosuccinate lyase reveals imperfect correlation of in-vitro enzyme activity with clinical phenotype in argininosuccinic aciduria.J Inherit Metab Dis. 2012 Jan;35(1):133-40. doi: 10.1007/s10545-011-9357-x. Epub 2011 Jun 11. J Inherit Metab Dis. 2012. PMID: 21667091
MeSH terms
LinkOut - more resources
Medical